CN105327340A - 一种抗衰老组合物及其制备方法 - Google Patents
一种抗衰老组合物及其制备方法 Download PDFInfo
- Publication number
- CN105327340A CN105327340A CN201510822958.3A CN201510822958A CN105327340A CN 105327340 A CN105327340 A CN 105327340A CN 201510822958 A CN201510822958 A CN 201510822958A CN 105327340 A CN105327340 A CN 105327340A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- powder
- senility
- radix angelicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 230000003005 anti-senility effect Effects 0.000 title abstract 5
- 239000000843 powder Substances 0.000 claims abstract description 33
- 241000756943 Codonopsis Species 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 8
- 239000002904 solvent Substances 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 4
- 229930195725 Mannitol Natural products 0.000 claims abstract description 4
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000000594 mannitol Substances 0.000 claims abstract description 4
- 235000010355 mannitol Nutrition 0.000 claims abstract description 4
- 239000002244 precipitate Substances 0.000 claims abstract description 4
- 210000000582 semen Anatomy 0.000 claims description 27
- 244000293323 Cosmos caudatus Species 0.000 claims description 14
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 230000002605 anti-dotal effect Effects 0.000 claims description 2
- 238000009837 dry grinding Methods 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 240000002948 Ophiopogon intermedius Species 0.000 abstract description 2
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001254604 Angelica pubescens Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000042430 Rhodiola rosea Species 0.000 abstract 1
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000007721 medicinal effect Effects 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 14
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 210000001541 thymus gland Anatomy 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- XLSLFPQAPYONPW-WHUHBCJBSA-N (2s,3s,4s,5r,6r)-6-[(r)-cyano(phenyl)methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O[C@@H](C#N)C1=CC=CC=C1 XLSLFPQAPYONPW-WHUHBCJBSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 241000208365 Celastraceae Species 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010058109 Hangnail Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- UNGXBWFICNLIRX-UHFFFAOYSA-N Laetrile Natural products NCC(OC1OC(C(O)C(O)C1O)C(=O)O)c2ccccc2 UNGXBWFICNLIRX-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000000336 Solanum dulcamara Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- -1 ceramide glucoside Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 229930002600 steroidal saponin Natural products 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种抗衰老组合物及其制备方法,所述抗衰老组合物由以下重量份的组分组成:珍珠粉、杏仁粉、白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩、红景天。制备方法为将上述各成分粉碎成能通过200目筛的粉末,加水超声煮沸至溶液体积为加热前溶剂体积的1/5,滤去沉淀;加入溶液重量1/10的甘露醇,搅拌至溶解;灌装即得。本发明为纯中药制剂,而且药性缓和,适合广大老年人使用。
Description
技术领域
本发明涉及医药领域,特别涉及一种口服液。
背景技术
衰老(senility)是指随着时间的推移,生命体自发的必然过程。随着社会的进步,人群的寿命也在不断延长,老年人数量在持续增加。在生理学上,把衰老看作是从受精卵开始一直进行到老年的个体发育史。从病理学上,衰老是应激和劳损,损伤和感染,免疫反应衰退,营养不足,代谢障碍以及疏忽和滥用积累的结果。由于老年人的身体机能已经衰退,一些对肝肾功能影响大的药物已经不适合老年人服用,因此开发一种药性缓和的、纯中药制剂的抗衰老药物有着很强的现实意义。
发明内容
针对上述技术问题,本发明提供一种抗衰老组合物及其制备方法。本发明的抗衰老组合物由以下重量份的组分组成:珍珠粉10~30份、杏仁粉30~50份、白芍5~15份、当归10~20份、甘草30~50份、麦冬5~15份、川芎5~15份、独活10~20份、薏仁10~20份、防风10~20份、党参5~15份、米糠10~20份、胶原蛋白粉10~20份、黄芩10~20份、红景天10~20份。
进一步地,由以下重量份的组分组成:珍珠粉15~25份、杏仁粉35~45份、白芍8~12份、当归12~17份、甘草35~45份、麦冬8~13份、川芎9~12份、独活13~18份、薏仁12~17份、防风12~18份、党参8~13份、米糠12~18份、胶原蛋白粉12~18份、黄芩12~18份、红景天12~18份。
具体地,由以下重量份的组分组成:珍珠粉20份、杏仁粉40份、白芍10份、当归15份、甘草40份、麦冬10份、川芎10份、独活15份、薏仁15份、防风15份、党参10份、米糠15份、胶原蛋白粉15份、黄芩15份、红景天15份。
本发明的抗衰老组合物的制备方法包括以下步骤:
(1).按配方量,将白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩与红景天晒干粉碎;
(2).加入珍珠粉、杏仁粉,混合均匀;
(3).将步骤(2)制得的混合粉末加入到5倍重量的水中,超声煮沸至溶液体积为加热前溶剂体积的1/5,滤去沉淀;加入溶液重量1/10的甘露醇,搅拌至溶解;
(4).每瓶5ml灌装即得。
优选地,所述粉碎后的白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩、红景天粉末以及珍珠粉和杏仁粉能通过200目筛。
上述任意一项所述抗衰老组合物在制备抗衰老的外用护肤品或药品中的用途。
本发明的各个组分中:
珍珠具有安神定惊、明目去翳、解毒生肌等功效,现代研究还表明珍珠粉在提高人体免疫力、延缓衰老、祛斑美白、补充钙质等方面都具有独特的作用。《本草纲目》卷六四记载如下:“珍珠味咸,甘寒无毒。镇心点目。涂面,令人润泽好颜色。涂手足,去皮肤逆胪,坠痰,除面斑,止泄。除小儿惊热,安魂魄。止遗精白浊,解痘疗毒。”
杏仁粉,含有丰富的纤维质、磷、铁、钙、维生素B17及不饱和脂肪酸等重要的营养元素。杏仁粉含有49%的杏仁油,可保养皮肤,淡化色斑,使皮肤白嫩。
白芍,味苦、酸,性微寒。归肝、脾经。具有养血调经,敛阴止汗,柔肝止痛,平抑肝阳。之功效,主治血虚萎黄,***,自汗,盗汗,胁痛,腹痛,四肢挛痛,头痛眩晕。
当归,味甘、辛,性温。归肝、心、脾经。具有补血活血,调经止痛,润肠通便之功效。主治血虚萎黄,眩晕心悸,***,经闭痛经,虚寒腹痛等。
甘草,味甘,性平。归心、肺、脾、胃经。具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药之功效,用于调和某些药物的烈性。
麦冬,“甘、微苦,微寒。主要含沿阶草苷、甾体皂苷、生物碱、谷甾醇、葡萄糖、氨基酸、维生素等,具有抗疲劳、清除自由基、提高细胞免疫功能以及降血糖的作用。另外,麦冬有镇静、催眠的疗效。
川芎,味辛,温;入肝、胆经。主治***,痛经,经闭,难产,胞衣不下,产后恶露腹痛,肿块等。
独活:味辛、苦,性微温。归肾、膀胱经。能够祛风除湿,痛痹止痛。主治风寒湿痹,要洗疼痛,少阴伏风头痛,风寒挟湿头痛。
薏仁:味甘、淡,性微寒。归脾;肺;肾经。薏仁具有一定的抑菌、抗病毒功效。长期服用,可以使皮肤光滑细腻、白净有光泽。
防风:味辛、甘,性微温。归膀胱、肺、脾、肝经。具有祛风解表,胜湿止痛之功效,用于外感表证,风疹瘙痒,风湿痹痛,破伤风正,脾虚湿盛。
党参:味甘性平,无毒。归脾、肺经。补中,益气,生津。治脾胃虚弱,气血两亏,体倦无力。党参所含有效成分对神经***有兴奋作用,能增强机体抵抗力,增加红细胞和血红蛋白。
米糠:苦甘、平、无毒。入脾、胃经。米糠中含有的神经酰胺糖苷有抑制黑色素生成的功效.用它制造化妆品可保皮肤湿润、白净。从米糠中提取阿魏酸,作为食品添加剂,具有吸附紫外线与防止氧化的作用。
黄芩:味苦,性寒。归肺、胆、脾、大肠、小肠经。具有清热燥湿,泻火解毒之功效。现代药理试验证实,黄芩具有抗血小板聚集及抗凝、降血脂、保肝、利胆、抗氧化及抗癌等作用。
红景天:味甘、苦,性平。归肺、心经。主治气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。
与现有技术相比,本发明为纯中药制剂,而且药性缓和,口味清甜,但不增加糖的摄入量,易于被接受。具有清除自由基,提高机体免疫功能,促进人体代谢,调节神经***功能,从而延缓人及脏器生理功能的退化和衰老过程,提高体质体力,提高精神,达到人体延缓衰老的目的,副作用小,可长期服用。适合广大老年人使用。
为了更好地理解和实施,下面详细说明本发明。
具体实施方式
制备实施例
本发明的抗衰老组合物的制备方法包括以下步骤:
(1).按表1配方量,将白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩与红景天晒干粉碎至能通过200目筛;
(2).加入珍珠粉、杏仁粉,混合均匀;
(3).将步骤(2)制得的混合粉末加入到5倍重量的水中,超声煮沸至溶液体积为加热前溶剂体积的1/5,滤去沉淀;加入溶液重量1/10的甘露醇,搅拌至溶解;
(4).每瓶5ml灌装即得。
<表1各组分配方量,以重量份计>
红景天甙含量测定实施例
按照《保健食品检验与评价技术规范》中“保健食品中红景天甙的测定”第一法进行。
红景天甙标准溶液:准确称取红景天甙标准品0.02g,加入加入溶解并定容至10ml。
试样处理:称取实施例1~5制得的样品各20ml分别于50ml量瓶中,先加入25ml甲醇,超声10min后用甲醇定容至刻度,混匀,再经0.45μm滤膜过滤,为供试品溶液。
色谱条件:色谱柱为C18柱,4.6×250×5μm;柱温为室温;检测波长215nm;流动相为甲醇:0.02mol/l乙酸钠溶液=9:91;流速为1.0ml/min。
标准曲线绘制:分别配置浓度为0、0.01、0.02、0.05、0.2、0.5μg/ml红景天甙标准溶液,在上述给定的色谱条件下进行分析,以峰面积对浓度做标准曲线。
测试过程:取10μl标准溶液及供试品溶液注入液相色谱仪,以保留时间定性,以试样峰面积与标准比较定量。
计算公式:X=(A1×C×V)/(A2×m×1000),其中:X为试样中红景天甙的含量,mg/g;A1为供试品峰面积;C为标准溶液浓度,μg/ml;V为试样定容体积,ml;A2为标准溶液峰面积;m为试样质量,g。结果如表2:
<表2>
效果实施例
1.对小鼠免疫器官的影响。
取体重为12-15的雄性KM小鼠140只,按体重随机分为实施例1~5组、市售品组和空白对照组共7组。每组20只小鼠。每天灌胃给药一次,对照组灌胃给同体积的蒸馏水,连续7天。末次给药24小时后,处死动物,称体重及胸腺、脾脏的重量,以胸腺或脾脏重量(mg)与体重(g)之比作为胸腺或脾脏系数。结果如表3:
<表3>
*为与市售品组对比,p<0.05;#为与对照组对比,p<0.05
2.对D-半乳糖损伤小鼠脂褐质含量和抗氧化功能酶活力的影响
选用三月龄健康昆明种小鼠雌雄各半共80只,18~20g。随机分为8组:正常组、模型组、市售品组、实施例1~5组。采用单笼饲养,自由摄食与饮水,室温18~20℃,日光灯辅助照明,每日维持光照12小时。
以生理盐水配制的0.96%D-半乳糖,5mg/kg体重,皮下注射造模,每日1次,连续造模6周。加药组经口给予不同受试样品,模型组和正常组给予同体积溶剂,在给受试样品的同时,除正常组外,各组继续给予相同剂量D-半乳糖皮下注射,正常组皮下注射生理盐水,实验结束处死动物,测脂褐质含量和抗氧化功能酶活力。测定结果进行统计处理,结果见表4:
<表4>
*为与市售品组对比,p<0.05;#为与模型组对比,p<0.05
本发明并不局限于上述实施方式,如果对本发明的各种改动或变形不脱离本发明的精神和范围,倘若这些改动和变形属于本发明的权利要求和等同技术范围之内,则本发明也意图包含这些改动和变形。
Claims (6)
1.一种抗衰老组合物,其特征在于由以下重量份的组分组成:珍珠粉10~30份、杏仁粉30~50份、白芍5~15份、当归10~20份、甘草30~50份、麦冬5~15份、川芎5~15份、独活10~20份、薏仁10~20份、防风10~20份、党参5~15份、米糠10~20份、黄芩10~20份、红景天1~5份。
2.根据权利要求1所述的一种抗衰老组合物,其特征在于由以下重量份的组分组成:珍珠粉15~25份、杏仁粉35~45份、白芍8~12份、当归12~17份、甘草35~45份、麦冬8~13份、川芎9~12份、独活13~18份、薏仁12~17份、防风12~18份、党参8~13份、米糠12~18份、黄芩12~18份、红景天2~4份。
3.根据权利要求2所述的一种抗衰老组合物,其特征在于由以下重量份的组分组成:珍珠粉20份、杏仁粉40份、白芍10份、当归15份、甘草40份、麦冬10份、川芎10份、独活15份、薏仁15份、防风15份、党参10份、米糠15份、黄芩15份、红景天3份。
4.一种制备如权利要求1~3任意一项所述的一种抗衰老组合物的方法,其特征在于包括以下步骤:
(1).按配方量,将白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩与红景天晒干粉碎;
(2).加入珍珠粉、杏仁粉,混合均匀;
(3).将步骤(2)制得的混合粉末加入到5倍重量的水中,超声煮沸至溶液体积为加热前溶剂体积的1/5,滤去沉淀;加入溶液重量1/10的甘露醇,搅拌至溶解;
(4).每瓶5ml灌装即得。
5.根据权利要求5所述的一种抗衰老组合物,其特征在于:所述粉碎后的白芍、当归、甘草、麦冬、川芎、独活、薏仁、防风、党参、米糠、黄芩、红景天粉末以及珍珠粉和杏仁粉能通过200目筛。
6.权利要求1~3任意一项所述抗衰老组合物在制备抗衰老的外用护肤品或药品中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510822958.3A CN105327340A (zh) | 2015-11-24 | 2015-11-24 | 一种抗衰老组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510822958.3A CN105327340A (zh) | 2015-11-24 | 2015-11-24 | 一种抗衰老组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105327340A true CN105327340A (zh) | 2016-02-17 |
Family
ID=55278245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510822958.3A Pending CN105327340A (zh) | 2015-11-24 | 2015-11-24 | 一种抗衰老组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105327340A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437231A (zh) * | 2020-04-18 | 2020-07-24 | 北温草生物科技(上海)有限公司 | 一种抗皱抗衰老的中草药组合物 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1279073A (zh) * | 2000-04-17 | 2001-01-10 | 李熙德 | 一种抗衰老的中药 |
CN101745034A (zh) * | 2008-12-10 | 2010-06-23 | 高莹 | 抗衰老延年益寿药 |
CN102178301A (zh) * | 2011-04-21 | 2011-09-14 | 深圳市唤然生物科技开发有限公司 | 一种蓝莓保健饮料及其制备方法 |
CN103316208A (zh) * | 2013-06-17 | 2013-09-25 | 邓占峰 | 具有补气养血、抗衰老、延年益寿的中药制剂 |
-
2015
- 2015-11-24 CN CN201510822958.3A patent/CN105327340A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1279073A (zh) * | 2000-04-17 | 2001-01-10 | 李熙德 | 一种抗衰老的中药 |
CN101745034A (zh) * | 2008-12-10 | 2010-06-23 | 高莹 | 抗衰老延年益寿药 |
CN102178301A (zh) * | 2011-04-21 | 2011-09-14 | 深圳市唤然生物科技开发有限公司 | 一种蓝莓保健饮料及其制备方法 |
CN103316208A (zh) * | 2013-06-17 | 2013-09-25 | 邓占峰 | 具有补气养血、抗衰老、延年益寿的中药制剂 |
Non-Patent Citations (3)
Title |
---|
周秋丽等: "《现代中药基础研究与临床》", 30 June 2012, 天津科技翻译出版公司 * |
武谦虎: "《常用治疗肝病中药》", 31 January 2014, 中国医药科技出版社 * |
范青生等: "《保健食品配方原理与依据》", 31 January 2007, 中药医药科技出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111437231A (zh) * | 2020-04-18 | 2020-07-24 | 北温草生物科技(上海)有限公司 | 一种抗皱抗衰老的中草药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112972547A (zh) | 一种治疗气血两虚症候的中药组合物及其制备方法和应用 | |
CN103041209B (zh) | 一种治疗肾阴虚的中药制剂及其制备方法 | |
CN107853517B (zh) | 一种提神抗疲劳的中药饮料及其制备方法 | |
CN105727145A (zh) | 用于治疗脾虚痰湿证型高脂血症的中药药物 | |
CN103301267B (zh) | 一种治疗高血压和/或动脉粥样硬化的中药组合物及应用 | |
CN103735662A (zh) | 一种人参阿胶药物组合物及其制备方法和用途 | |
CN102688471B (zh) | 一种具有抗疲劳作用的复方制剂 | |
CN106177053A (zh) | 一种包含青钱柳叶和陈皮的降血糖保健组合物 | |
CN104825914A (zh) | 一种辅助治疗乳腺癌症的中药制剂 | |
CN104225417A (zh) | 一种辅助改善记忆力功能的中药组合物及其制备方法 | |
CN105434738A (zh) | 一种治疗小儿多动症的中药组合物及其制备方法 | |
CN107125751B (zh) | 龟粉、制备方法及其应用 | |
CN105327340A (zh) | 一种抗衰老组合物及其制备方法 | |
CN104587299A (zh) | 一种治疗胃及十二指肠溃疡的中药制剂 | |
CN104524174A (zh) | 一种治疗风湿痹痛的中药组合物及其制备方法 | |
CN104042895A (zh) | 一种治疗***性红斑狼疮的中药组合物及其用途 | |
CN103446280A (zh) | 一种三七提取物、川芎提取物、红花提取物、葛根提取物与山楂提取物的组合药物及其制剂、应用 | |
CN104257839B (zh) | 一种具有降糖降脂保护血管内皮作用的中药组合物及其制备方法 | |
CN103933386B (zh) | 一种用于治疗血友病的复方血友胶囊及其制备方法 | |
CN105250208A (zh) | 一种抗衰老组合物及其制备方法 | |
CN105233272A (zh) | 一种抗衰老组合物及其制备方法 | |
CN105233273A (zh) | 一种抗衰老组合物及其制备方法 | |
CN105288596A (zh) | 一种抗衰老组合物及其制备方法 | |
CN105267956A (zh) | 一种抗衰老组合物及其制备方法 | |
CN106177476A (zh) | 一种包含石斛和陈皮的降血糖保健组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160217 |
|
RJ01 | Rejection of invention patent application after publication |